Home » Cell Plans to Pay up to $30 Million for Drug
Cell Plans to Pay up to $30 Million for Drug
Biotech firm Cell Therapeutics today will announce plans to pay Biogen Idec up to $30 million for a lymphoma cancer treatment.
The Seattle Times
Upcoming Events
-
07May
-
14May
-
30May